Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

NCT05957042 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped Responsible Party left the institution and the study will not be started by other investigator

Conditions

Interventions

Sponsor

Milton S. Hershey Medical Center